Article

Michelle Esser Discusses Two Encouraging Breast Cancer Studies

Author(s):

Michelle Esser, program manager for research and advocacy, Young Survival Coalition, discusses two encouraging studies presented during the 2015 annual meeting of the American Society of Clinical Oncology (ASCO).

Michelle Esser, program manager for research and advocacy, Young Survival Coalition, discusses two encouraging studies presented during the 2015 annual meeting of the American Society of Clinical Oncology (ASCO), a Chicago gathering of nearly 30,000 oncology professionals in May and June.

Esser was particularly encouraged by discussions surrounding ovarian suppression, surgery and bisphosphonate use in premenopausal women with breast cancer. Esser also mentions a study conducted by Hatem Abdel Azim that looked at genetic differences in breast cancer of young and older women.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
image of gerds
Image of 2 doctors and text.
Image of two doctors and text.
Image of man.
Image of thumbnail.
Patients can prepare personal overviews to help care teams connect with them as individuals, explained Michelle Kirschner in an interview with CURE.
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Expanding on a New Way to Manage Polycythemia Vera Without Iron Deficiency
Image of woman.
Image of two people.